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Abstract The purpose of this article is to investi-
gate the prevalence of plaque prolapse (PP) after
Xience V and Taxus Liberte stent implantation.
During the study period 2006–2007, 200 consecutive
patients underwent coronary revascularization for de
novo lesions and received an intravascular ultrasound
(IVUS) post-stenting evaluation, (n = 124 patients
with Taxus Liberte and n = 76 with Xience V) (227
stent segments). Cross-sectional and longitudinal 3D
IVUS images were analyzed in a blind fashion,
evaluating the prevalence of PP and calculating its
depth and angle. The angulation degree of the
coronary artery at the lesion site pre-stent implanta-
tion was also evaluated by angiography. The preva-
lence of PP was 23.9% in Xience V versus 38.1% in
Taxus Liberte (P = 0.025). The depth and angle of
PP were greater in Taxus Liberte stent than Xience V
stent (0.4 ± 0.1 mm versus 0.5 ± 0.2 mm, P =
0.004; and 32.0 ± 8.9 versus 44.6 ± 27.6, P =
0.044, respectively). The angulation degree of the
coronary artery at the lesion site was higher in
presence of plaque prolapse than in its absence
(48.2 ± 29.3 vs. 38.2 ± 28.1, P = 0.013). By
multivariate analysis, stent type was independently
associated with incidence of plaque prolapse. Xience
V stent has less plaque prolapse than Taxus Liberte
stent. Stent design may play a role in the prevalence
of plaque prolapse.
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Introduction
Plaque prolapse (PP) is commonly defined as tissue
extrusion through the stent strut post-procedure and is
observed more frequently by IVUS than coronary
angiography [1, 2]. Several investigators have raised
concerns (i.e. stent thrombosis and restenosis) about
PP after implantation of bare metal stents and first
generation drug eluting stents (DES) [3, 4].
Compared to bare metal stents, drug eluting stents
are associated with lower rates of restenosis. [5].
However, late stent thrombosis became the funda-
mental Achilles’ heel of DES. Although not firmly
established, PP and incomplete stent apposition have
been considered to play a role in the pathogenesis of
late stent thrombosis [6].
The platform changes of Taxus Liberte stent were
intended to improve device delivery and drug release
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versus the Taxus Express 2 [7]. A second generation
DES, the Xience V stent, was also shown to reduce
restenosis rates and long-term MACE events com-
pared to BMS and some first and second generation
DES [8, 9]. There are, however, no studies to date
examining the relationship between PP and second
generation DES.
Thus, the aim of the present study was two-fold:
(1) to compare the prevalence of PP, as assessed by
cross-sectional and three dimensional volumetric
IVUS imaging, in patients treated with Xience V
and Taxus Liberte implantation and (2) to identify
patient or procedural factors associated with PP.
Methods
Population
A total of 410 consecutive patients were evaluated
with IVUS after percutaneous coronary intervention
(PCI) for de novo lesions in our cath lab between
January 2006 and December 2007. We excluded
patients with acute myocardial infarction (AMI)
within the preceding 2 weeks. During the study
period, 80% of patients were implanted either with
the Xience V (polymer-based, everolimus-eluting,
Abbott Vascular, Santa Clara, CA, USA) or Taxus
Liberte (polymer-based, paclitaxel-eluting, Boston
Scientific Corporation, Natick, MA, USA) stent.
Patients treated with other stents were excluded.
Thus, we analyzed the data of 200 patients with 227
stented segments (with newly implanted stents) that
were associated with good quality IVUS images.
Coronary stent procedure
Coronary angioplasty was performed according to
standard practice. When multi-segment or multi-
vessel treatment was performed, all implanted stents
were of the same type.
All patients were treated with oral aspirin indefinitely
(100–300 mg/daily) and clopidogrel (300 mg loading
dose and 75 mg/daily maintenance dose for 1 year).
Quantitative coronary angiographic analysis
Vessel curvature (i.e. angulation) at the lesion site
was measured in Rubo Dicom viewer system (Rubo
Medical Imaging BV, Aerdenhout, The Netherland)
both pre- and post-stenting [10]. The measurement
was done on a still frame at end diastole in the same
angiogram view selected by the interventional cardi-
ologist, who was blinded to stent type, pre and post-
stenting (Fig. 1) Angulation measurements were
performed by an analyst who was blind to the stent
type. Diameter stenosis, lesion length, minimal lumen
Fig. 1 This illustration shows the methodology of defining the
vessel curvature angle pre-stenting and post-stenting. Upper In
Rubo DicomViewer, we can only measure the angle a with two
tangents to the proximal and distal parts of the stenosis/stents at
the end-diastolic angiographic frame. We calculate the angle b
to represent the angulation of the vessel. Middle An example of
Xience V stent pre and post-stent angle changes in LCX. Lower
An example of Taxus Liberte stent pre and post-stent angle
changes in RCA
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diameter, and reference vessel diameter before and
after intervention were analyzed off-line (CAAS II,
Pie-Medical, Maastricht, The Netherlands).
IVUS imaging protocol
Intravascular ultrasound images were acquired using
a motorized pullback at a constant speed of 0.5 mm/s
(30 frames). Images were recorded on high-resolution
CD for off-line analysis. Two types of IVUS catheter
were used during the study period: (1) Eagle Eye
20 MHz (Volcano Corporation, Rancho Cordova,
USA) in 29 patients (14.5%) and (2) Atlantis pro
40 MHz (Boston Scientific/Cardiovascular Imaging
System, Maple Grove, Minnesota) in the remaining
171 patients (85.5%). Two independent experienced
investigators reviewed the IVUS images and were
blinded to stent type. As definition of plaque prolapse
was evaluated as qualitative variable in previous
reports [3, 4, 11, 12], we defined PP as quantitative
variable as a tissue protrusion into the vessel lumen
measuring at least 0.15 mm passed the boundary of
the stent area. Intra and inter-observer variabilities
were calculated for PP identification. As the strut
thickness of the first generation DES is approximately
0.15 mm, this threshold was used in our definition.
The stent area was defined by planimetry of the area
bounded by stent struts. In Rubo Dicom viewer
system, we measured (1) the maximum depth of PP
across the stent (2) the angle of PP using the center of
the vessel as a reference point and (3) the percentage
of depth of PP relative to stent diameter (Fig. 2).
Quantitative 3D IVUS analysis was performed
using a dedicated quantitative IVUS analysis system
(Curad IVUS Analysis 4.1.8, Wijk bij Duurstede, The
Netherlands). The quantitative IVUS analysis system
enables semiautomatic contours detection of the
lumen, vessel, and stent as well as quantitative analysis
of their dimensions in longitudinal and cross-sectional
views. The resulting cross-sectional Bezier contours
can be visualized immediately superimposed on a
running video loop and may be edited manually. The
mathematical description consists of a connected
series of Bezier curves. Lumen, stent areas were
measured along the entire target segment. This system
has been validated and used in previous clinical studies
[13]. The volume of PP was automatically calculated
by subtracting lumen volume from stent volume.
Statistical analysis
All normally distributed data were expressed as % or
mean ± SD. Normal distribution of the variables was
tested by Kolmogorov–Smirnov test. Group differ-
ences of categorical variables were compared using
Pearson chi-squared tests. A kappa co-efficient was
estimated to evaluate the inter-observer agreement of
identification of plaque prolapse. Comparison of
means was done using independent-samples t test.
Multivariate logistic regression analysis was per-
formed to identify independent factors of PP. An
exploratory univariate analysis was used to identify
the variables to included in the multivariate model
(only the variables with a P value of \0.15 and the
pre-stenting lesion angle, as possible confounding
factor, were included). A P value of \0.05 was
considered significant, and all tests were two-tailed.
Data were analyzed with SPSS version 16.0 software
(SPSS Inc., Chicago, IL).
Results
The baseline patient characteristics were similar
between the Xience V and Taxus Liberte groups
(Table 1). The mean age of the patients was 64 years
old. The majority were male (70%) and the most
frequently treated vessel was left anterior descending
(54.5%). At pre-stenting, the angle at site lesion was
significant lower in Xience V group compared to
Taxus Liberte group (34.8 ± 24.2 vs. 45.7 ± 30.7,
P = 0.003); the change in angulation from pre- to
post-stenting was larger in Taxus Liberte stent com-
pared to Xience V (16.3 ± 18.6 vs. 10.8 ± 11.5,
P = 0.006) (Table 1).
Fig. 2 This figure depicts defining the center of the lumen,
measurement of PP angle, depth and percentage of depth. The
center of gravity utilise intersection of the shortest and longest
diameter
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In total, there were 74 (32.6%) PP sites as assessed
by IVUS (Figs. 3, 4). PP was observed more com-
monly in Taxus Liberte (53/139, 38.1%) than Xience V
(21/88, 23.9%) (P = 0.025). The depth and angle of PP
were significantly larger in Taxus Liberte than Xience
V (0.54 ± 0.20 mm vs. 0.40 ± 0.11 mm, P = 0.004
for PP depth; and 44.66 ± 27.60 vs. 32.05 ± 8.97,
P = 0.044 for the angle) (Table 2). Intra- and inter-
observer variabilities for PP evaluation yielded good
concordance (j = 0.90 and j = 0.84, respectively).
At pre-stenting, sharper angles were found in
patients with PP compared to those without PP
(48.2 ± 29.3 vs. 38.2 ± 28.1, P = 0.013) (Table 3).
Lesions characteristics in patients with PP tended to be
more complex compared to those in patients without
PP (P = 0.06). The pre-stent angle between Xience V
and Taxus Liberte was not significant different among
patients without PP, while was significantly different
among patients with PP (35.9 ± 21.8 versus 53.4 ±
31.8, P = 0.010) (Fig. 5).
Table 1 Baseline clinical
(n = 200) and lesion
characteristics (n = 227) as
to different type of stent
* Total cholesterol C
5.0 mmol/l or treatment
with a lipid-lowering drug.
LAD left anterior
descending artery, LCX left
circumflex artery, RCA right
coronary artery, LM left
main, MLD pre minimal
lumen diameter
pre-intervention
Baseline clinical characteristics Xience V
N = 76
Taxus Liberte
N = 124
P
Age (years) 64 ± 9.74 63 ± 10.35 0.378
Male (%) 71.1 69.4 0.799
Diabetes (%) 18.4 16.1 0.675
Hypertension (%) 50 46.8 0.658
Dyslipidemia*(%) 52.6 62.9 0.152
Smoking (%) 36.8 50.8 0.052
Family history (%) 44.7 48.4 0.616
No. of coronary arteries narrowed [ 50% (n) 0.089
1 vessel 39 59
2 vessel 23 53
3 vessel 14 12
Clinical presentation (n) 0.913
Stable angina 49 79
Unstable angina 27 45
Lesion characteristics Xience V (n = 88) Taxus (n = 139)
Target vessel (n) 0.307
LAD 52 72
LCX 19 26
RCA 13 34
LM 2 6
Intermediate 2 1
Lesion characteristics (n) 0.174
Type A 30 33
Type B1 44 69
Type B2 9 26
Type C 5 11
Maximum angle () 34.4 ± 23.7 40.6 ± 24.3 0.056
Pre-stenting angle () 34.8 ± 24.2 45.7 ± 30.7 0.003
Post-stenting angle () 24.4 ± 19.5 29.7 ± 22.4 0.060
Angle change () 10.8 ± 11.5 16.3 ± 18.6 0.006
MLD pre (mm) 0.75 ± 0.39 0.82 ± 0.53 0.269
Vessel size (mm) 3.12 ± 0.51 3.25 ± 0.59 0.094
Lesion length (mm) 29.8 ± 15.1 30.5 ± 15.8 0.722
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In the multivariate analysis, including all variables
with P \ 0.15 in univariate analysis, only the type of
stent implanted was the independent predictor of
plaque prolapse (Table 4).
Discussion
The main observations of this study were the
following: (1) plaque prolapse was more commonly
Fig. 3 Left panel Right coronary artery (RCA) angiogram post-stent. Proximal RCA TAXUS Liberte stent 3.5*18 mm (between
white arrows). Right panel plaque prolapse in IVUS (40 mHz Atlantis Pro), with plaque depth 0.52 mm and angle 29
Fig. 4 Left panel Left circumflex (LCX) angiogram post-stent,
mid-LCX has a Xience V stent 3.0*18 mm (between two
white arrows). Big white arrow indicated the approximate
angiographic location of the plaque prolapse seen in the IVUS.
Right panel plaque prolapse in IVUS (20 mHz Eagle Eye),
with plaque depth 0.56 mm and angle 37
Table 2 IVUS
characteristics of plaque
prolapse between Xience V
and Taxus Liberte
Variables Xience V (n = 21) Taxus Liberte (n = 53) P
Plaque volume (mm3) 0.33 ± 0.42 1.06 ± 2.23 0.145
Depth (mm) 0.40 ± 0.11 0.54 ± 0.20 0.004
Depth (%) 13.7 ± 3.87 15.8 ± 5.50 0.115
Angle () 32.05 ± 8.97 44.66 ± 27.60 0.044
Length (mm) 1.10 ± 1.48 1.46 ± 1.30 0.305
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observed in the Taxus Liberte group than in the
Xience V group; (2) presence of plaque prolapse was
associated with sharper angle at the lesion site; (3)
geometrical characteristics of plaque prolapse were
different between the two stent groups.
Plaque prolapse was first reported in 1994 using
coronary angiography and described as residual stenosis
and haziness [14]. IVUS technology confirmed the
suspicions of plaque prolapse noted by angiography.
Studies of BMS and first generation DES (sirolimus-
eluting Cypher and paclitaxel-eluting Taxus stent)
documented PP rates between16.6 to 41% [3]. In this
retrospective observational study, approximately one
third of patients were identified with PP by IVUS.
Table 3 Comparison of
patients having prolapse
and their counterparts
* Total cholesterol C
5.0 mmol/L or treatment
with a lipid-lowering drug.
PP plaque prolapse, LAD
left anterior descending
artery, LCX left circumflex
artery, RCA right coronary
artery, LM left main, MLD
pre minimal lumen
diameter pre-intervention
Variable PP(?) N = 74 PP(-) N = 153 P
Age (years) 63 ± 11.4 64 ± 9.7 0.542
Men (%) 67.6 71.2 0.571
Diabetes (%) 17.6 17.0 0.914
Hypertension (%) 48.6 49 0.958
Dyslipidemia* (%) 60.8 53.6 0.305
Smoking (%) 51.4 41.2 0.148
Family history (%) 47.3 45.8 0.827
Stent type (%) 0.013
Xience V 27.0 44.5
Taxus Liberte 73.0 55.5
No. of coronary arteries narrowed [ 50% (n) 0.783
1 vessel 37 69
2 vessel 27 62
3 vessel 10 22
Clinical presentation (n) 0.147
Stable angina 41 100
Unstable angina 33 53
Target vessel (n) 0.179
LAD 40 84
LCX 13 32
RCA 24 27
LM 0 8
Intermediate 1 2
Lesions characteristics ((n, (%)) 0.06
Type A 15 (20) 48 (31)
Type B1 35 (47) 78 (51)
Type B2 16 (21) 19 (12)
Type C 8 (12) 8 (6)
Direct stenting (%) 30.5 69.5 0.527
Post-dilatation (%) 15 20 0.785
Max post-dilatation balloon pressure, mean ± SD 17.1 ± 2.2 16.9 ± 2.3 0.716
Pre-stenting angle () 48. 2 ± 29.3 38.2 ± 28.1 0.013
Post-stenting angle () 31.9 ± 22.6 25.6 ± 20.6 0.037
Angle change () 16.4 ± 19.2 12.6 ± 15.3 0.115
Lesion length (mm) 32.7 ± 15.3 29.0 ± 15.5 0.092
Vessel size (mm) 3.17 ± 0.49 3.21 ± 0.48 0.607
MLD pre (mm) 0.72 ± 0.47 0.83 ± 0.49 0.093
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Lesion characteristics may contribute to the plaque
prolapse. Previous studies have demonstrated that
plaque prolapse may occur with greater frequency in
the setting of long lesions, chronic total occlusions,
positive remodeling and thrombus [3, 12]. In the
present study, we found that the pre-stenting
angulation at the lesion site was higher in the lesions
with plaque prolapse. As vessel curvature at the
lesion site has been demonstrated as a predictor of
major adverse cardiac events [15], an increased
frequency of plaque prolapse in those patients could
represent a link between vessel curvature and clinical
outcomes.
Procedural characteristics may also play a role in
the prevalence of PP. In our study, all the procedures
were performed by the same group of interventional
cardiologists using similar techniques. No obvious
differences in procedural characteristics were
observed between the two stent types groups.
Although most stent designs can adequately cover
atherosclerotic plaques, PP may also be related to
struts’ geometry and design. Previous studies have
shown similar rates of plaque prolapse between
Taxus and Cypher stents [3]. In our analysis, we
found a greater incidence of prolapse in the Taxus
Liberte stent than Xience V stent (38.2% vs. 23.9%,
P = 0.025). The difference in type of metal or design
between these two stent could be accounted for the
higher incidence of plaque prolapse. In particular,
previous studies and data from manufactures have
shown that the maximum cell opening and the metal
artery wall ratio (percentage of artery wall covered by
the outer surface of the stent) between Taxus Liberte
and the Xience V were different (Table 5) [16].
However, despite an higher metal artery wall ratio,
Taxus exhibits a higher plaque prolapse incidence.
For this reason, difference in stent design could be
probably more important in determining plaque
prolapse. Taxus Liberte is a stainless steel platform
and open cell design [17]. On the other side, the
Xience V stent is a multi-link vision cobalt chromium
stent platform and is also an open cell concept with
two designs for small and larger vessels [8]. Although
there was a different angiographic vessel curvature
between Xience V with Taxus Liberte groups, at
multivariate regression analysis, stent type was still
an independent predictor of plaque prolapse (OR
1.86, 95%CI 1.00, 3.47, P = 0.050).
Limitations
This study suffers from the inherent limitations of any
small size, retrospective, non-randomized study.
Coronary segment angle degree measured by 2D
software suffers from the limitation of 2D
Fig. 5 Vessel curvature parameters in patients without plaque
prolapse (panel A) and in patients with plaque prolapse (panel
B)
Table 4 Univariate and multivariate analysis of independent
predictors of plaque prolapse
Variables Univariate
analysis
Multivariate
analysis
Clinical setting P = 0.05 P = 0.05
Lesion length P = 0.54
Stent type P = 0.04 P = 0.03
Pre-stenting MLD P = 0.54
Pre-stenting lesion angle P = 0.28 P = 0.17
Angle change after stenting P = 0.50
Lesion characteristics, according to
AHA/ACC classification
P = 0.11 P = 0.06
Maximum balloon pressure P = 0.34
MLD minimum lumen diameter
Int J Cardiovasc Imaging
123
measurement. The limitation of IVUS to differentiate
PP tissue characteristics and the limited sensitivity of
IVUS to identify small plaque prolapse may have also
confounded the observed rate of plaque prolapse after
stenting.
In addition, it has been reported that using optical
coherence tomography technology, which is associ-
ated with greater resolution, plaque prolapse can be
observed in more than 70% of patients [18]. Thus, the
true prevalence of plaque prolapse is still unclear and
can vary depending on the imaging modality and
definition used.
Conclusion
Plaque prolapse rate is higher after Taxus Liberte
stent implantation compared to Xience V stent
implantation. The importance of stent design and
lesion characteristics in the pathogenesis of plaque
prolapse need further elucidation.
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